Patents Represented by Attorney Yonggang Ji
  • Patent number: 7655794
    Abstract: The invention provides an improved method for the purification of nucleic acid molecules, which method comprises generating a cellular lysate containing the nucleic acid; contacting the lysate with an anion exchanger bound to a solid support matrix under conditions such that the anion exchanger binds the nucleic acid; followed by eluting the nucleic acid from the anion exchanger with an aqueous mobile phase comprising an elution solution; and desalting the eluted nucleic acid such that it is suitable for downstream applications. The improvement of the method includes providing the anion exchanger in a packed column, wherein the column is packed using a salt solution containing an antimicrobial agent. In addition, the salt solution has a salt concentration similar to that of the lysate, such that the column does not need equilibration prior to sample loading.
    Type: Grant
    Filed: September 19, 2007
    Date of Patent: February 2, 2010
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Sudhakar Rao Takkellapati, Rajesh Ambat
  • Patent number: 7655793
    Abstract: Disclosed is a process for separating and/or purifying a nucleic acid by elution of the nucleic acid from anion exchange resins under conditions of high salt concentration and the presence in the eluant of an additive comprising guanidine, or a guanidine-like derivative. The process allows high recovery of nucleic acids from anion exchange resins without impairing the nucleic acid stability as compared with conventional ion exchange chromatographic procedures.
    Type: Grant
    Filed: September 19, 2007
    Date of Patent: February 2, 2010
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Sibylle Herzer, Sudhakar Rao Takkellapati, Rajesh Ambat
  • Patent number: 7655792
    Abstract: The invention provides an improved method for the purification of nucleic acid molecules, which method comprises generating a cellular lysate containing the nucleic acid; contacting the lysate with an anion exchanger bound to a solid support matrix under conditions such that the anion exchanger binds the nucleic acid; followed by eluting the nucleic acid from the anion exchanger with an aqueous mobile phase comprising an elution solution; and desalting the eluted nucleic acid such that it is suitable for downstream applications. The improvement of the method includes adding in the elution solution a composition such that the pH of the aqueous mobile phase is between about pH 9 and about pH 13, wherein the presence of the composition in the elution solution provides an increase in nucleic acid recovery, as compared with the recovery in the absence of the composition.
    Type: Grant
    Filed: September 19, 2007
    Date of Patent: February 2, 2010
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Sudhakar Rao Takkellapati, Rajesh Ambat
  • Patent number: 7651599
    Abstract: The present invention discloses a high-density parallel channel design for a microfabricated capillary array electrophoresis chip, with vertical T or double T design for sample injection. An alternative embodiment of the invention includes a closed buffer reservoirs with integrated electrodes and buffer feeding ports. Also disclosed are novel sample loading and injection methods, including the use of using either a capillary array connected to an electrode, or an array of metal pens as the loader/electrode.
    Type: Grant
    Filed: September 25, 2003
    Date of Patent: January 26, 2010
    Assignee: GE Healthcare (SV) Corp.
    Inventors: Iuliu-Ioan Blaga, Jing Ni, William D. Nielsen
  • Patent number: 7645903
    Abstract: The present invention relates to an IgG-binding compound, which more specifically has affinity for human IgGs of ?-type and functional derivatives thereof. More specifically, the compound according to the invention comprises an N,N-alkylated urea moiety located between an aromatic part and another part, which is a linear or cyclic substituted or unsubstituted aliphatic group. The compound binds to a pocket-shaped binding site present on all human IgG ?-Fabs, which site is located between the two domains (CH1 and CL) of its constant part. Accordingly, the compound according to the invention is a ligand for human IgGs of ?-type, and consequently, the invention also relates to a separation matrix for affinity chromatography, which matrix comprises said compound, as well as to other uses of the compound.
    Type: Grant
    Filed: September 12, 2003
    Date of Patent: January 12, 2010
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Andreas Axén, Herbert Baumann, Enrique Carredano, Anna Grönberg, Elles Steensma
  • Patent number: 7642058
    Abstract: The invention relates to a method of characterizing interaction between two species in a liquid environment, wherein a liquid comprising said at least one species is passed as a flow through a measurement system, and wherein the interaction takes place within said measurement system. The method comprises generating a concentration gradient of at least a first one of said species or of at least one other species having an influence on the interaction or on interacted components. The flow of liquid is passed through a sensor device, and a result of interaction between said at least two species is detected. The flow of liquid is intersected at least once with a further liquid before the flow is passed through said sensor, so as to create at least two separated liquid segments having different concentrations of at least one of said species forming the concentration gradient.
    Type: Grant
    Filed: June 4, 2004
    Date of Patent: January 5, 2010
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Karl Andersson, Christina Wass
  • Patent number: 7635426
    Abstract: A filtration housing is disclosed.
    Type: Grant
    Filed: November 7, 2003
    Date of Patent: December 22, 2009
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Martin J. Weinstein, Attila Herczeg
  • Patent number: 7625838
    Abstract: The present invention relates to a chromatographic adsorbent for selectively adsorbing IgG, comprising the following formula and its corresponding enol-form, wherein X represents O, S, or NH; R1 represents H, C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxy-C1-6 alkyl, Ar, —C(O)NHR3, —C(O)—R3 or halo; R2 represents H, C1-3 alkyl or halo; R3 represents H, C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxy-C1-6 alkyl or Ar; n represents 0, 1, 2 or 3; Y represents a carrier. The present invention also relates to a method of producing said adsorbent as well as use thereof for separating substances by affinity chromatography.
    Type: Grant
    Filed: June 17, 2009
    Date of Patent: December 1, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Mathias Alterman, Andreas Axen, Enrique Carredano, Anna Gronberg, Jinyu Zou
  • Patent number: 7612189
    Abstract: The present invention relates to polypeptide and nucleic acids constructs which are useful for determining the cell cycle status of a mammalian cell. Host cells transfected with these nucleic acid constructs can be used to determine the effects that test agents have upon the mammalian cell cycle.
    Type: Grant
    Filed: July 22, 2005
    Date of Patent: November 3, 2009
    Assignees: GE Healthcare UK Limited, Vanderbilt University
    Inventors: Suzanne Hancock, Simon Stubbs, Nicholas Thomas, Ellen Fanning, Jinming Gu
  • Patent number: 7608187
    Abstract: The present invention relates to method of manufacturing a sulphonate-functionalized (S-functionalized) cation exchanger, which method comprises reacting olefinic groups with bisulphite in the presence of at least one amine oxide, such as N-methyl morpholine oxide (NMO). The olefinic groups of the carrier may be allyl groups; which may be provided on extenders such as polyhydroxyfunctional polymers. In one embodiment, the carrier is made of agarose with improved flow pressure properties.
    Type: Grant
    Filed: November 16, 2006
    Date of Patent: October 27, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Andreas Axen, Gunnar Glad, Henrik Ihre, Anders Larsson, Nils Norrman
  • Patent number: 7582487
    Abstract: Methods and devices are provided for controlling a fluid flow over a sensing surface within a flow cell. The methods employ laminar flow techniques to position a fluid flow over one or more discrete sensing areas on the sensing surface of the flow cell. Such methods permit selective sensitization of the discrete sensing areas, and provide selective contact of the discrete sensing areas with a sample fluid flow. Immobilization of a ligand upon the discrete sensing area, followed by selective contact with an analyte contained within the sample fluid flow, allows analysis by a wide variety of techniques. Sensitized sensing surfaces, and sensor devices and systems are also provided.
    Type: Grant
    Filed: December 6, 2005
    Date of Patent: September 1, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Magnus Malmqvist, Håkan Roos, Stefan Sjölander, Mattias Tidare, Håkan Sjödin, Ralph Stålberg
  • Patent number: D598125
    Type: Grant
    Filed: March 27, 2008
    Date of Patent: August 11, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventor: Sven Wounder
  • Patent number: D599235
    Type: Grant
    Filed: December 2, 2008
    Date of Patent: September 1, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventor: Thomas Oberg
  • Patent number: D599236
    Type: Grant
    Filed: December 2, 2008
    Date of Patent: September 1, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventor: Thomas Oberg
  • Patent number: D600579
    Type: Grant
    Filed: August 25, 2008
    Date of Patent: September 22, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventor: Sven Wounder
  • Patent number: D600580
    Type: Grant
    Filed: August 25, 2008
    Date of Patent: September 22, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventor: Sven Wounder
  • Patent number: D601912
    Type: Grant
    Filed: January 16, 2007
    Date of Patent: October 13, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Klaus Gebauer, Sven Wounder, Stefan d'Argy, Dan Hermansson, Roger Lundqvist
  • Patent number: D602168
    Type: Grant
    Filed: June 22, 2007
    Date of Patent: October 13, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Dan Hermansson, Roger Lundqvist
  • Patent number: D603965
    Type: Grant
    Filed: February 26, 2007
    Date of Patent: November 10, 2009
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Kaushal Verma, Joseph Masino, Pavel A. Fomitchov, Liqin Wang
  • Patent number: D608014
    Type: Grant
    Filed: May 27, 2009
    Date of Patent: January 12, 2010
    Assignee: GE Healthcare Bio-Science AB
    Inventors: Sven Wounder, Tomas Haukkala, Ida Sundqvist